62例患者应用刺五加注射剂安全性分析  

Analysis of the safety for the Ciwujia Injection Used in 62 Patients

作　　者：周学琴[1] 郭长杰[1] 

机构地区：[1]北京大学深圳医院药剂科,广东深圳518036

出　　处：《中国药物警戒》2005年第4期213-214,共2页Chinese Journal of Pharmacovigilance

摘　　要：目的了解刺五加注射剂在临床应用中的安全性,促进临床合理用药。方法对该院2003年6月30日～2005年3月30日所使用刺五加注射剂的住院患者用药情况及出现的不良反应进行调查分析。结果按照药品说明书规定的剂量,以0.9%氯化钠注射液或5%～10%葡萄糖注射液作为溶媒,单独配制且单独静脉滴注,滴注速度30～50滴/分时较为安全。结论应严格按照药品说明书的规定合理用药,以减少药品不良反应的发生。Objective To understand the safety of Ciwujia injection in clinical use.Methods The adverse drug reactions and administration of Ciwujia ingection at Peking University Shenzhen Hospital from June,2003 to March,2005 were Investigated. Results According to the dosage in drug introduction,it was safer and induced less ADR when Ciwujia injection was diluted in 0.9% sodium chloride injection or in 5%-10% glucose injection and infused alone with a infusion rate of 30- 50 drops/min.Conclusioa Use of this preparation should strictly be in accordance with the specification.

关 键 词：刺五加注射剂 安全性 分析 

分 类 号：R283.611[医药卫生—中药学] R994.11[医药卫生—中医学]